TELO — Telo Genomics Share News
0.000.00%
Last trade - 00:00- CA$5.52m
- CA$5.86m
Brief: Telo Genomics Announces Final Assignment Of Patents On Hematological Cancers, Liquid Biopsy & Alzheimer's Disease
Brief: Telo Genomics Announces Multiple Myeloma Collaboration With Mayo Clinic
Brief: 3D Signatures Announces Name Change To Telo Genomics Corp
Brief: 3D Signatures Says Current Board And Executive Management Team Do Not Intend To File For Bankruptcy
Brief: 3D Signatures Announces Intention To File For Bankruptcy
Brief: 3D Signatures Signed Collaboration Agreement With Mdxhealth SA To Evaluate Co's Prognostic Test Candidate For Prostate Cancer
Brief: 3D Signatures Inc Announces Changes To Its Board Of Directors
Brief: 3D Signatures Inc Announces Upsizing Of $1,500,000 Private Placement
Brief: 3D Signatures reports first quarter financial results for fiscal 2018
Brief: 3D SIGNATURES ANNOUNCES PRIVATE PLACEMENT FOR PROCEEDS OF UP TO $2.5 MLN
Brief: 3D Signatures announces changes to its Board, audit committee
Brief: 3D Signatures says completion of Stage 3 of Hodgkin's Lymphoma Test Validation Program
Brief: 3D Signatures Inc. announces short form prospectus offering to raise up to C$5 million
Brief: 3D Signatures receives first prostate cancer blood samples for clinical trial
Brief: 3D Signatures software identifies patients with Alzheimer's disease from cheek swab
Brief: 3D signatures new initiative to distinguish between two forms of lung cancer